Zero Nitrous Oxide Emissions
Microbial synthesis eliminates the generation of N2O , making it a dramatically greener process than the conventional route.
Adipic Acid (ADA) is a crucial dicarboxylic acid, primarily used as a monomer for synthesizing Nylon 6,6 and as a component in polyurethanes. Conventional industrial synthesis relies on petrochemical feedstocks (cyclohexane/benzene), a process notorious for high emissions in petrochemical synthesis , particularly the release of nitrous oxide (N2O), a potent greenhouse gas. Biosynthesis offers a green alternative but is hampered by incomplete biosynthetic pathways in native hosts and tight regulation, resulting in low conversion rates and industrial viability.
CD Biosynsis offers a synthetic biology service focused on achieving high-titer, sustainable ADA production. Our core strategy involves modification of Escherichia coli fatty acid metabolism pathway , rerouting the highly efficient fatty acid degradation (beta-oxidation) cycle to function in reverse for the synthesis of the C6 intermediate (Hexanoyl-CoA). This is coupled with the overexpression of key enzymes for adipic acid synthesis , specifically the reductase/oxidase cascade necessary to convert the C6 fatty acid intermediate into the final Adipic Acid product. This integrated approach aims to deliver a high-yield, pure, and environmentally sustainable Adipic Acid product, avoiding the N2O emissions of petrochemical routes.
Get a QuoteTransitioning to competitive biosynthetic Adipic Acid production faces these key challenges:
A successful solution must establish a complete, high-flux pathway for ADA synthesis and ensure its efficient export.
CD Biosynsis utilizes advanced metabolic engineering to optimize Adipic Acid production in E. coli :
Modification of E. coli Fatty Acid Metabolism Pathway
We engineer the beta-oxidation pathway to operate in reverse (the reductive mode) for chain elongation, specifically focusing on the production of the C6 intermediate, Hexanoyl-CoA.
Overexpression of Key Enzymes for Adipic Acid Synthesis
We introduce and overexpress the heterologous enzymes (e.g., dehydrogenases and oxidoreductases ) required to convert Hexanoyl-CoA into the final product, Adipic Acid.
Competing Pathway Blockage
We use CRISPR technology to knock out native enzymes (thioesterases and degradation enzymes) that consume the Hexanoyl-CoA intermediate for other cellular functions.
Co-factor and Redox Balance Optimization
We tune the central metabolism (e.g., PPP) to ensure sufficient NADPH supply , which is essential for the high-yield operation of the fatty acid synthesis pathway in the reductive mode.
This systematic approach is focused on establishing a complete and highly specific pathway for ADA synthesis in the host.
Our Adipic Acid engineering service is dedicated to pursuing the following production goals:
Zero Nitrous Oxide Emissions
Microbial synthesis eliminates the generation of N2O , making it a dramatically greener process than the conventional route.
Renewable Feedstock Utilization
The host uses low-cost sugars or biomass derivatives instead of non-renewable benzene/cyclohexane as the carbon source.
High Adipic Acid Titer and Purity
Targeted pathway construction minimizes side products, leading to a cleaner broth and simpler purification. [Image of Cost Reduction Icon]
Reduced Energy Consumption
Fermentation occurs under mild temperature and pressure, significantly reducing the overall energy footprint compared to petrochemical processes.
Flexible Biosynthetic Route
The fatty acid pathway can be tuned to produce other diacids or monomers (C}4$, C}5$, C}8$) by adjusting pathway enzymes.
We provide a sustainable and cost-effective biosynthetic platform for industrial Adipic Acid production.
Our Adipic Acid strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product purity.
Explore the potential for a high-performance, green Adipic Acid supply. CD Biosynsis provides customized strain engineering solutions:
What is the main use of Adipic Acid?
The primary use of Adipic Acid (over 90%) is as a monomer for the production of Nylon 6,6 , a durable synthetic polymer used in fibers and engineering plastics.
Why is the reverse beta-oxidation pathway used?
The beta-oxidation pathway is naturally used for fatty acid degradation . Running it in reverse (reductive mode) allows for the efficient, stepwise synthesis of carbon chains (Hexanoyl-CoA), providing a robust platform for C6 synthesis.
What is the environmental benefit of biosynthesis?
The main benefit is the elimination of N2O (nitrous oxide) emissions , which are an unavoidable byproduct of the petrochemical synthesis of Adipic Acid and a major contributor to global warming.
What is the challenge with the terminal oxidation step?
The terminal oxidation involves converting a CoA-linked C6 molecule into the final dicarboxylic acid. This three-step conversion (reductase $\rightarrow$ dehydrogenase} \rightarrow \text{oxidase) requires efficient and specific heterologous enzymes that are often the major bottleneck in the pathway.
What is the estimated project timeline?
A project involving complex multi-gene heterologous pathway construction, reverse flux engineering, and host optimization in E. coli typically requires 20-24 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.